Bharat Express DD Free Dish

Cipla

Sensex gained 291 points, and Nifty closed above 24,100 on Monday, supported by buying in IT and pharma stocks and softer crude oil prices.

Indian markets extend losses for sixth week as Sensex, Nifty fall amid West Asia tensions, currency volatility and rising crude prices.

Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled multiple products from the US market after the regulator flagged manufacturing-related issues.

Sensex & Nifty indices opened under pressure, reflecting concerns over new US tariffs on pharma imports & persistent foreign fund outflows.

The Indian stock market opened nearly flat on Friday, with benchmark indices showing little movement amid mixed global trends.

From January 2026, Cipla Limited will be manufacturing Galvus and Galvus combination brands that are used in the treatment of type 2 diabetes